Literature DB >> 2460575

Day-night rhythm of 5-methoxytryptamine biosynthesis in the pineal gland of the golden hamster (Mesocricetus auratus).

A M Galzin1, M T Eon, H Esnaud, C R Lee, P Pévet, S Z Langer.   

Abstract

5-Methoxytryptamine is a potent agonist of presynaptic 5-hydroxytryptamine autoreceptors modulating serotonin release in the central nervous system. This methoxyindole can be synthesized in the pineal gland, but its presence in vivo is still controversial, probably because of rapid catabolism by monoamine oxidase. An improved high-pressure liquid chromatography method, with coulometric detection, has been developed for the simultaneous measurement of melatonin, 5-methoxytryptamine, 5-methoxytryptophol and 5-methoxyindolacetic acid. We have demonstrated a day-night rhythmicity in the amount of 5-methoxytryptamine in the pineal gland of golden hamsters (Mesocricetus auratus) maintained under a long photoperiod (14 h light: 10 h darkness) and pretreated with the monoamine oxidase inhibitor pargyline. Levels of 5-methoxytryptamine were highest at 16.30 h and lowest at 00.30 h. The rhythm for 5-methoxytryptamine appears to be the same as for serotonin (opposite in phase to that of melatonin). The identification of 5-methoxytryptamine has been confirmed by analysis with gas chromatography-mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460575     DOI: 10.1677/joe.0.1180389

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  Effect of different photoperiods on the diurnal rhythm of 5-methoxytryptamine in the pineal gland of golden hamsters (Mesocricetus auratus).

Authors:  F Raynaud; P Pévet
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 2.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

3.  Plasma concentrations of 5-methoxytryptamine, 5-methoxytryptophol and melatonin after 5-methoxytryptamine administration of golden hamsters: physiological implications.

Authors:  F Raynaud; B Vivien-Roels; M Masson-Pévet; P Pévet
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Low temperature in the golden hamster accelerates the gonadal atrophy induced by short photoperiod but does not affect the daily pattern of melatonin secretion.

Authors:  P Pévet; B Vivien-Roels; M Masson-Pévet
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

5.  Cytochemical localization of type-A and -B monoamine oxidase in the rat pineal gland.

Authors:  M Masson-Pévet; P Pévet
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

6.  Melatonin metabolism in the central nervous system.

Authors:  Rüdiger Hardeland
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

7.  Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes.

Authors:  D M Rotroff; M H Shahin; S B Gurley; H Zhu; A Motsinger-Reif; M Meisner; A L Beitelshees; O Fiehn; J A Johnson; M Elbadawi-Sidhu; R F Frye; Y Gong; L Weng; R M Cooper-DeHoff; R Kaddurah-Daouk
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-10-29

Review 8.  Taxon- and Site-Specific Melatonin Catabolism.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2017-11-21       Impact factor: 4.411

9.  Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.

Authors:  Hongjie Zhu; Mikhail B Bogdanov; Stephen H Boyle; Wayne Matson; Swati Sharma; Samantha Matson; Erik Churchill; Oliver Fiehn; John A Rush; Ranga R Krishnan; Eve Pickering; Marielle Delnomdedieu; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

10.  Diurnal profiles of melatonin synthesis-related indoles, catecholamines and their metabolites in the duck pineal organ.

Authors:  Bogdan Lewczuk; Natalia Ziółkowska; Magdalena Prusik; Barbara Przybylska-Gornowicz
Journal:  Int J Mol Sci       Date:  2014-07-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.